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Polycomb-group RING finger homologs (PCGF1,
PCGF2, PCGF3, PCGF4, PCGF5, and PCGF6)
are critical components in the assembly of distinct
Polycomb repression complex 1 (PRC1)-related
complexes. Here, we identify a protein interaction
domain in BCL6 corepressor, BCOR, which binds
the RING finger- and WD40-associated ubiquitin-
like (RAWUL) domain of PCGF1 (NSPC1) and
PCGF3 but not of PCGF2 (MEL18) or PCGF4
(BMI1). Because of the selective binding, we have
named this domain PCGF Ub-like fold discriminator
(PUFD). The structure of BCOR PUFD bound to
PCGF1 reveals that (1) PUFD binds to the same
surfaces as observed for a different Polycomb group
RAWUL domain and (2) the ability of PUFD to
discriminate among RAWULs stems from the identity
of specific residues within these interaction surfaces.
These data show themolecular basis for determining
the binding preference for a PCGF homolog, which
ultimately helps determine the identity of the larger
PRC1-like assembly.
INTRODUCTION
Polycomb group (PcG) proteins form repressive complexes that
mediate epigenetic modifications of histones (Simon and
Kingston, 2009). The Drosophila PcG protein PSC is a key player
in multiple PcG complexes with different functions. As amember
of Drosophila Polycomb repression complex 1 (PRC1)
(Figure 1A), PSC helps to create a compacted chromatin state
that is inaccessible to chromatin remodeling enzymes (Shao
et al., 1999), a function that PSC can carry out on its own (Francis
et al., 2001). In a related complex, the N-terminal RING finger
heterodimer of PSC and dRING1 act as a ubiquitin ligase (E3)
to modify histone H2A (Wang et al., 2004). The dRAF complex
is yet another PSC-containing complex that includes dKDM2,Structure 21whose demethylation of dimethylated histone 3 Lys 36
(H3K36me2) is coupled to H2A E3 activity (Lagarou et al.,
2008). PSC is also part of a cell cycle regulatory complex
(Mohd-Sarip et al., 2012). In humans, the expansion to six
different PSC orthologs (PCGF1/NSPC1, PCGF2/MEL18,
PCGF3, PCGF4/BMI1, PCGF5, and PCGF6/MBLR) has resulted
in the functional diversification of the complexes they assemble
into (Figure 1B). While PCGF2 and PCGF4 are part of complexes
most similar to Drosophila PRC1 (Gao et al., 2012; Levine et al.,
2002), PCGF1 assembles into a dRAF-like complex that includes
KDM2B, a H3K36me2 demethylase, and BCOR (Gao et al.,
2012; Gearhart et al., 2006; Sa´nchez et al., 2007).
A closer look at the individual protein-protein interactions
within these PcG complexes provides clues indicating how
distinct larger assemblies could emerge (Figure 1B). In particular,
a ubiquitin-like fold domain involved in protein interactions called
ring finger- and WD40-associated ubiquitin-like (RAWUL)
(Sanchez-Pulido et al., 2008) appears to be key in determining
the identity of the larger assembly. A recent study has shown
that the binding partners to the RING1B RAWUL and the identity
of the PCGF homolog define the larger assemblies (Gao et al.,
2012). The contribution made by the RING1B RAWUL (also
called C-RING1B) toward forming a distinct larger assembly
likely stems from its ability to utilize a mutually exclusive binding
surface to associate with short peptides within different proteins
that can be quite diverse in sequence (Wang et al., 2010). The
RAWUL domains of the PCGF proteins appear to play a similar
role, given that the RING finger domain of the PCGF homologs
plays the singular role of heterodimerizing with RING1B to facil-
itate the H2A E3 activity (Buchwald et al., 2006; Li et al., 2006;
Wang et al., 2004), thus leaving the RAWUL domain to play the
part of helping to define the larger assembly. The ability of the
PCGF RAWUL to bind different proteins (Alkema et al., 1997;
Gunster et al., 1997; Kyba and Brock, 1998; Lee et al., 2007)
supports this notion.
The direct binding partner of PCGF1 is BCOR (Gearhart et al.,
2006), which has emerged as an important player in develop-
ment and health. Mutation of BCOR results in oculofaciocardio-
dental syndrome (Ng et al., 2004). Bcor is required for appro-
priate regulation of gene expression during differentiation
mouse embryonic stem cells (Wamstad et al., 2008). BCOR is, 665–671, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 665
Figure 1. PRC1-like Assemblies
(A) Two PSC-containing Drosophila PcG complexes are shown. The dashed
line indicates that the protein-protein interactions required to assemble
dKDM2 into the complex are unknown.
(B) Distinct mammalian PcG complexes are in part defined by the RAWUL
binding reactions. The figure is similar to the one proposed by Gao et al. (Gao
et al., 2012), which identified the RING1B RAWUL-binding partners along with
the PCGF homologs as playing a key role in defining distinct PRC1-like
assemblies. The phylogenetic tree of the PCGF proteins is based on the
sequence alignment of their RAWUL domains.
Structure
Structural Basis for PCGF1/BCOR Selectivityinvolved in mediating transcriptional repression by the oncopro-
tein BCL6 and thus likely plays an active role in the development
of BCL6-driven lymphomas (Gearhart et al., 2006; Huynh et al.,
2000). In two other cancers, BCOR is involved in translocations;
a fusion of BCOR with retinoic acid receptor alpha has been
observed in an acute promyelocytic leukemia (Yamamoto
et al., 2010), while a BCOR-CCNB3 gene fusion has been found
in Ewing sarcomas that are distinct from those caused by the
more familiar EWS-ETS fusions (Pierron et al., 2012). In contrast,
emerging data suggest that, in other cancers, BCOR plays
a tumor suppressive role. Mutation of BCOR has been found in
brain tumors (Pugh et al., 2012), retinoblastomas (Zhang et al.,
2012), and acute myeloid leukemia (AML) (Grossmann et al.,
2011). The closely related homolog BCOR-like 1 (BCORL1) has
also been implicated in AML (Li et al., 2011).
The assembly of the different PcG complexes is dependent on
the binding preferences of the PCGF homologs. More specifi-
cally, the binding of PCGF1 to BCOR will lead to assembly of
the dRAF-like complex, while PCGF2 and PCGF4 binding to
the PcG protein called polyhomeotic (PHC1, PHC2, and PHC3)
results in formation of the mammalian PRC1 equivalents
(Figure 1). To better understand the molecular determinants
underlying the formation of different human PcG complexes,
we investigated the binding selectivity and the structural basis
for how PCGF1 RAWUL binds directly to a previously unidenti-
fied protein interaction domain at the C terminus of BCOR.
RESULTS
PUFD Is a Protein Interaction Domain Selective for
PCGF1 and PCGF3
We first mapped the minimum essential binding regions within
PCGF1 and BCOR (Figures 2A and 2B). Using the bacterial
two-hybrid assay, in which the interaction between two target
proteins results in expression of the b-lactamase reporter gene
(Dove and Hochschild, 2004), the PCGF1 RAWUL (Figure 2C)
was found to be sufficient to obtain a positive signal of bacte-
rial growth in ampicillin media when coexpressed with BCOR
1451–1755 (Figure 2B, top left panel). BCOR 1451–1755 is the
previously identified region required for binding PCGF1 (Gear-
hart et al., 2006). Further dissection of this interaction revealed
that BCOR 1634–1748 is both necessary and sufficient for
interaction with the PCGF1 RAWUL. The 115 BCOR residues
were a surprisingly large region to be bound by a RAWUL
domain as the one in RING1B (also called C-RING1B; Wang
et al., 2010), PCGF2 and PCGF4 (see below) form stable
complexes with approximately 30 residue peptides of their
respective binding partners. A BLAST search of BCOR 1634–
1748 finds matches only in the related human protein called
BCORL1 and in BCOR orthologs in other species (Figure 2D).
We have named this protein interaction domain PCGF Ub-like
fold discriminator (PUFD).
We were unable to isolate the PCGF1 RAWUL alone,
precluding a more thorough investigation of its interaction with
the PUFD or any other potential binding partners. We were,
however, able to isolate the PCGF1/PUFD complexes through
coexpression of both components in bacteria and perform sedi-
mentation velocity experiments. At 8.5 mM, the lowest possible
concentration allowable for 280 nm absorption detection in our666 Structure 21, 665–671, April 2, 2013 ª2013 Elsevier Ltd All rightschosen buffer, an s value of 2.5 for the complexes was
observed (Figure 2E). Using a genetic algorithm-Monte Carlo
analysis (Brookes and Demeler, 2006; Demeler and Brookes,
2008), the molecular weights were calculated to be 22 and
26 kDa for the PCGF1 RAWUL in complex with the PUFD from
BCOR and BCORL1, respectively (Figure S1 available online).
This closely matches the expected 25 kDa for the complex, indi-
cating that PCGF1 RAWUL forms a stable complex with the
PUFDs with an equilibrium dissociation constant under 8.5 mM.
We next investigated whether the PCGF RAWULs could
discriminate between their binding partners (Figure 2F). In bacte-
rial two-hybrid assays, the PCGF2 and PCGF4 RAWULs exhibit
a positive binding signal with PHC1 HD1 but not with BCOR or
BCORL1 PUFDs. In contrast, the PCGF1 and PCGF3 RAWULs
bind the PUFDs of BCOR and BCORL1 but do not interact with
PHC1 HD1. Consistent with this result, PCGF3 has been found
in the same complex with BCORL1 (Gao et al., 2012). These
results highlight the different binding selectivities of the PCGF
RAWULs.
PCGF1 RAWUL/PUFD Structure Reveals Conserved
Binding Surfaces on the RAWUL
To probe the molecular basis for how the RAWULs discriminate
between binding partners, we determined the crystal structures
of the PCGF1 RAWUL in complex with the PUFD of BCOR and
also with BCORL1 (Figures 3A and S2; Table S1). The structure
of the PUFD core shows similarity to the dachshund homology
domain (Kim et al., 2002; Wilson et al., 2004; Figure S3A;
comparison of the RING1B and PCGF1 RAWULs is shown in
Figure S4). However, the PUFD displays clear deviations fromreserved
Figure 2. BCOR PUFD Binds PCGF1 Ub Fold
(A) Domains of PCGF1, BCOR, and BCORL1 are shown. *, Although the RefSeq for BCORL1 is lacking an exon encoding a portion of the first ankyrin repeat, this
exon is almost always included in human and other species’ complementary DNAs.
(B) The minimum BCOR region required to bind PCGF1 was determined using bacterial two-hybrid assay. The PCGF1 RAWUL (167–255) was coexpressed with
the indicated residues of BCOR.
(C and D) The sequence alignments of (C) RAWULs and (D) PUFDs are shown. The NCBI gene ID for theDrosophila melanogaster protein is CG14073. Sheets and
helices are indicated by arrows and cylinders. The secondary structure of RING1B is indicated below its sequence. Conserved hydrophobic and polar residues
are dark- and light-shaded, respectively. *, Residues that make intermolecular contacts are highlighted.
(E) van-Holde-Weischet integral distribution plot (Demeler and van Holde, 2004) of the PCGF1 RAWUL/PUFD complexes.
(F) Bacterial two-hybrid assay of the RAWULs of PCGF2, PCGF4, PCGF1, and PCGF3 show selective binding abilities. PCGF5 RAWUL produced all negative
results. Due likely to its toxicity, PCGF6 RAWUL could not be subcloned and was thus not tested.
See also Figure S1.
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Structural Basis for PCGF1/BCOR Selectivitythe core of this fold that affords PUFD the unique ability to bind
PCGF1 (Figure S3B). PCGF1 RAWUL and BCOR PUFD form an
intermolecular b sheet similar to that observed between RING1B
and either RYBP or CBX7 (Wang et al., 2010; Figure 3B).
However, while both RYBP and CBX7 form their b sheets from
20 consecutive residues, the BCOR PUFD is unique in that
its N and C termini come together to form the b sheet. A key
residue at the PCGF1 b sheet surface is Val 206, which packs
against BCOR Phe 1639. In the RING1B RAWUL, a Tyr residue
is at a position in the RAWUL equivalent to Val 206 (RING1B
Try 262). This position may play a key discriminatory role in se-
lecting the binding partner of the RAWUL (see below). As in
the RING1B RAWUL, a second surface, the loop-binding
surface, is present on PCGF1 (Figure 3C). Like RING1B Tyr
247, which is central to creating its loop-binding surface,
PCGF1 Tyr 191 is at the equivalent position and plays a similar
role. A third binding surface is present in PCGF1, which we refer
to as the Leu cage because it completely encases BCOR Leu
1706 (and the equivalent BCORL1 Leu 1665) (Figure 3D).Structure 21As noted above, we were unable to isolate the PCGF1 RAWUL
alone or the RAWULs from any of the other PCGF homologs in
order to quantitatively assess their binding interactions. As far
as we are aware, no such studies have yet to be reported for
any PCGF RAWUL, likely reflecting their instability, which we
have observed. However, we could make qualitative assess-
ments regarding the function of the RAWULs using the bacterial
two-hybrid assay. This assay presents an advantage in sensi-
tivity in that even proteins that express insolubly in bacteria
can still yield a binding signal. Using this assay, we assessed
the contribution made by each of the binding surfaces (Figures
4A and 4B). Consistent with the important role for Val 206
observed in the crystal structure, the PCGF1 Val206Asp mutant,
a b sheet surface mutation, shows no positive interaction signal.
Similarly, loop-binding surface mutations Tyr191Ala and
Arg193Ala show hindered binding to BCOR. We cannot rule
out the possibility that the negative results are the consequence
of the mutations hindering the ability of the PCGF1 RAWUL to
form the proper three-dimensional structure rather than, 665–671, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 667
Figure 3. Structure of PCGF1 RAWUL/
BCOR PUFD Complex
(A) The asymmetric unit of the PCGF1 RAWUL/
BCOR PUFD crystal structure is shown.
(B–D) Views are close-ups of (B) b sheet-, (C) loop-,
and (D) Leu cage-binding surfaces. Residues are
labeled in different colors for PCGF1 and BCOR.
See also Figures S2–S4 and Table S1.
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Structural Basis for PCGF1/BCOR Selectivitya consequence of disrupting specific contacting residues
required for stable complex formation. However, Try191,
Arg193, and Val206 are all mostly solvent exposed in the
absence of PUFD (83%, 81%, and 62%, respectively), and
thus these mutations would be expected to have less of an
impact on folding than mutations within the core of the RAWUL.
It is also worth noting that PCGF1 Tyr 191 and Val 206 are equiv-
alent to RING1B Tyr 247 and Tyr 262. When these RING1B resi-
dues are mutated to Ala, it did not result in disrupting the tertiary
structure of the RING1B RAWUL (Wang et al., 2010), thus
providing an additional assurance that the PCGF RAWUL struc-
tures would likely tolerate the mutations. The Leu cage appears
to contribute less to binding compared to the other surfaces, as
BCOR Leu1706Asp or Arg (also BCORL1 Leu1665Asp or Arg)
showed little difference from wild type.
RAWUL Binding Selectivity Requires Matched Surface
Complementarity
Because equivalent binding surfaces on the RAWULs of both
PCGF1 and RING1B are utilized for binding, it would seem likely
that PCGF2 and PCGF4 also bind similarly to their binding part-
ners. Indeed, PCGF2 and PCGF4 mutations predicted to be at
both the b sheet and loop-binding surfaces resulted in far fewer
colonies than wild type in their interaction with PHC1 HD1
(Figure 4C). The unavailability of the structure of PCGF2 or
PCGF4 bound to HD1 precludes knowing the precise structural
features that provide the binding selectivity of the PCGF
proteins. However, comparative analysis with RING1B indicates
that binding surfaces of the interacting partnersmust be comple-
mentary without steric clashes or gaps (Figure 5). Unlike the
PCGF1 RAWUL, the RING1B RAWUL-binding partners are
much shorter in length, binding to a stretch of 30 residues within
the CBX homologs, called the cbox domain, and also to 35 resi-
dues within a protein called RYBP (Wang et al., 2010; Figure 5A,668 Structure 21, 665–671, April 2, 2013 ª2013 Elsevier Ltd All rights reservedcompare the CBX7 cbox in yellow to the
purple PUFD). Despite this difference,
the binding modes of the RAWULs show
many similarities. RING1B Tyr 262 is in
the equivalent position as PCGF1 Val
206. When RING1B RAWUL is overlayed
onto PCGF1 RAWUL, the large aromatic
side chain of RING1B Try 262would steri-
cally clash (Figure 5B, red arrow) with the
BCOR Phe 1641, thereby precluding
binding between RING1B and BCOR.
In contrast, the smaller side chain of
PCGF1 Val 206 can accommodate
BCOR Phe 1641. The lack of a large
hydrophobic residue in CBX7 (or RYBP)equivalent to BCOR Phe 1641 would also result in a large gap
at the interface (Figure 5C, red shading), disfavoring interactions
between PCGF1 and CBX7. The binding selectivity predicted by
this overlay analysis was confirmed in the bacterial two-hybrid
assay (Figure 5D). The RAWULs of PCGF1 and RING1B show
no binding signal with the other RAWUL-binding partner. These
results suggest that surface complementarity likely plays an
important role in determining binding selectivity.
DISCUSSION
In sum, we present structural and functional data that reveal how
a RAWUL of a PCGF homolog recognizes its binding partner.
The PCGF1 RAWUL uses the same binding surfaces as the
RING1B RAWUL, suggesting other PCGF RAWULs interact
with their respective binding partners in a similar fashion. Despite
this similarity in bindingmodes, very small differences in the con-
tacting surfaces of the PCGF RAWULs are likely to result in
completely changing their binding preference and, conse-
quently, the identities of the larger multiprotein complex.
Our study suggests that specific residues on both the b-sheet
and loop interactions surfaces are critical in selectively binding
their partners. Whereas modeling PCGF4 and PCGF2 residues
over PCGF1 can be informative in showing the differences with
PCGF1, determining the precise basis of the binding selectivity
remains a difficult task. The structures of these other RAWUL
complexes will have to be determined to understand the precise
structural determinants required for PCGF2 and PCGF4 to bind
the PHC proteins.
The identity of the PCGF homologs helps distinguish the larger
multiprotein complex that assembles (Gao et al., 2012; Figure 1).
RING1B in all these complexes can easily be accounted for
through its RING finger domain interaction with the RING finger
domain of the PCGF homologs. We have shown that the PCGF
Figure 4. Bacterial Two-Hybrid Assay
Testing Binding of Structure-Guided
Mutants
(A) PCGF1 RAWUL housing the indicated muta-
tions were coexpressed with the PUFDs of BCOR
and BCORL1.
(B) Mutations to the PUFD Leu residue encased by
the PCGF1 RAWUL ‘‘Leu cage’’ did not disrupt
binding.
(C) PCGF2 and PCGF4 RAWUL residues equiva-
lent to those in PCGF1 that are important for
binding the BCOR PUFD are required to bind
PHC1 HD1. The panels are aligned with the
equivalent positions shown in (A).
Structure
Structural Basis for PCGF1/BCOR SelectivityRAWUL performs a selective binding function, which, given the
PCGF homolog role in defining the larger complex, could further
play a key role in the assembly of the distinct higher order PRC1-
related complex. It is possible that the RAWUL interactions may
be more than a simple 1:1 protein interaction module but also
assist in bringing together the other components, leading to
assembly of the distinct PRC1-related complex. Future investi-
gation of these proteins will be required to determine the role
that the PCGF1/BCOR interaction plays, if any, in the overall




All genes of PCGF RAWULs (encompassing the following residues: PCGF1
167–255, PCGF2 121–229, PCGF3 152–242, and PCGF4 127–228) were
cloned into pTRG as a fusion with the a-subunit of RNA polymerase. All other
genes were cloned into pBT, creating a fusion with bacteriophage l repressor
protein (lcI). PHC1 HD1 encompasses PHC1 residues 720–760. Results using
genes cloned in the opposite vector often produced negative results and are,
thus, not reported. Mutations were introduced using QuikChange Site-
Directed Mutagenesis Kit (Agilent). Chemical competent BacterioMatch
(Stratagene) reporter cells were transformed with miniprepped plasmid DNA
and plated out onto LB agar plates containing 100 mg/ml ampicillin, 50 mg/ml
tetracycline, and 25 mg/ml chloramphenicol. Images of the plates were taken
after 16 hr incubation at 37C.
Protein Expression/Purification
The genes encoding BCOR 1634–1748 and BCORL1 1594–1711 were cloned
into a modified pET-30a (Novagen) vector, which contained a METR leader
sequence. The gene-encoding PCGF1 RAWUL, residues 167–255, was
cloned into a modified pET-3c (Novagen) vector with a leader sequence con-
taining a hexahistidine tag and a tobacco etch virus (TEV) recognition site
(MHHHHHHAMKGVDSPSAELDKKAENLYFQGTR). Either BCOR or BCORL1
were coexpressed with PCGF1 in BL21 Gold (DE3) cells (Stratagene) pretrans-
formed with the pRARE plasmid (Novagen), maintaining both expression plas-
mids in the presence of kanamycin and ampicillin. Selenomethionine (SeMet)
was incorporated following a previously published protocol (Van Duyne et al.,Structure 21, 665–671, April 2, 20131993). Briefly, proteins were purified by resus-
pending cells from 1 l of culture in 10 ml of buffer
containing 50 mM Tris pH 8.0, 200 mM NaCl,
10 mM imidazole pH 7.5, 10 mM b-mercaptoetha-
nol, and 5% glycerol. Cells were lysed by sonica-
tion and proteins partially purified using Ni affinity
chromatography. The N-terminal leader sequence
on PCGF1was cleaved using TEV and subtilisin for
the native PCGF1/BCOR and PCGF1/BCORL1
complexes, respectively. The SeMet PCGF1/BCOR complex was not subjected to protease treatment. Additional purifica-
tion steps included ion exchange and gel filtration chromatography.
Analytical Ultracentrifugation
Experiments were conducted using a Beckman Optima XL-I analytical ultra-
centrifuge. The PCGF1 RAWUL complexes with the PUFDs were prepared
to a concentration of 8.5 mM in 10 mM tris pH 8.0, 50 mM NaCl, and 1 mM
TCEP. Experiments were scanned in intensity mode at 280 nm, 20C, 35
krpm in standard two-channel epon centerpieces (Beckman-Coulter). Ultra-
scan III (Demeler, 2005) (version 2.0 release 1498, January 2013) was used
to analyze the data.
X-Ray Crystallography
Native PCGF1/BCORcomplex crystalswere grown in 50mM2-(N-morpholino)
ethanesulfonic acid pH 6.6, 8.5% polyethylene glycol (PEG) 8000, 300 mM
sodium bromide, and 10% ethylene glycol using hanging drop vapor diffusion.
SeMet-substituted PCGF1/BCOR crystals were grown in 100 mM tris pH 8.5,
10% PEG 8000, and 200 mM sodium acetate. The PCGF1/BCORL1 complex
crystallized in 100 mM sodium citrate pH 4.5, 19% PEG 1500, and 100 mM
dibasic sodium phosphate. A single-wavelength anomalous diffraction data
set for the SeMet-substituted PCGF1/BCOR crystal was collected at the
Advanced Photon Source (APS) beamline 21-ID-F, processed using XDS
(Kabsch, 2010), and input into autoSHARP (Vonrhein et al., 2007) to generate
an interpretable electron densitymap. The overall figure ofmerit to 2.45 A˚ reso-
lution was 0.38 before density modification. An initial model was built using
Coot (Emsley and Cowtan, 2004) and then refined against the native 2.1 A˚
data set collected at the Advanced Light Source beamline 4.2.2. The refined
PCGF1/BCOR structure was used as the search model for the 1.9 A˚ native
PCGF1/BCORL1 data set collected at APS beamline 21-D-F. Molecular
replacement using PHASER (Storoni et al., 2004) identified a solution contain-
ing twoPCGF1/BCORL1 complexes in the asymmetric unit. All structureswere
refined using PHENIX (Adams et al., 2002). Ramachandran statistics (Chen
et al., 2010) are as follows: PCGF1/BCOR: favored 98.42%, allowed 1.05%,
outliers: 0.53%; PCGF1/BCORL1: favored 98.94%, allowed 1.06%, 0%
outliers. All figures were prepared using Chimera (Pettersen et al., 2004).
ACCESSION NUMBERS
Protein Data Bank (PDB) IDs are 4HPL for PCGF1/BCOR and 4HPM for
PCGF1/BCORL1.ª2013 Elsevier Ltd All rights reserved 669
Figure 5. Binding Specificity between RAWULs and Binding
Partners Require Matched Surface Complementarity
(A) The asymmetric unit of the PCGF1 (cyan)/BCOR (purple) structure is
shown. The entire CBX7 cbox (yellow) from the RING1B/CBX7 structure (PDB
ID: 3GS2) is overlayed, showing the contiguous nature of its b sheet in contrast
to that of BCOR, which is formed by bringing together the BCORPUFD termini.
The region highlighted by the oval is equivalent to the areas that are magnified
in (B) and (C).
(B) The BCOR b sheet (purple) is overlayed on the CBX7 b sheet of the RING1B
RAWUL (gray)/ CBX7 cbox structure (Wang et al., 2010). The red arrow indi-
cates potential steric clash.
(C) CBX7 cbox is overlayed on BCOR of the PCGF1/BCOR structure. The red
shading shows potential gap that could disfavor the interaction between
PCGF1 and CBX7.
(D) Cross-binding between the RAWULs (PCGF1 and RING1B) and their
respective binding partners was tested using the bacterial two-hybrid assay.
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